drugset / Trial / NCT06590155

Erythropoietin in HIE Neonate

NCT06590155

Phase 0 Not yet recruiting 3 enrolled Assiut University
RandomizedSingle-groupOpen-labelPrevention

Summary

this study is aim to delineate the role of erythropoietin in improving neonatal hypoxic ischemic encephalopathy the study is conducted to answer the question : is erythropoietin will improve neonatal hypoxic ischemic encephalopathy?

Timeline

Start
2024-11-24
Primary completion
2029-02-24
Completion
2029-02-24

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic

Indications